New Delhi, July 15 (IANS) The Central government launched Phase‑III of the Biomedical Research Career Programme with a total outlay of Rs 1,500 crore to expand fellowships, research grants and translating discoveries into practical healthcare applications, an official statement said on Wednesday.

The outlay includes Rs 1,000 crore from the Department of Biotechnology and Rs 500 crore from the London‑based Wellcome Trust, the statement from the Ministry of Science & Technology said.

The programme aims to nurture a globally competitive biomedical research workforce comprising basic scientists, clinician-researchers, public health experts, science communicators and research managers while creating greater opportunities for interdisciplinary and collaborative research, said Union MoS Science & Technology, Earth Sciences, Dr. Jitendra Singh.

He added that the initiative would also attract new philanthropic and international partnerships, multiplying the impact of India’s investments in biomedical science.

Dr Singh said biotechnology is set to become the defining force behind India’s next phase of economic growth, scientific advancement and global competitiveness

The minister noted India’s bioeconomy has expanded nearly twenty‑fold from $10 billion in 2014 to more than $195 billion in 2025 and is projected to touch $300 billion by 2030.

India today hosts nearly 12,000 biotechnology startups, has emerged among the world’s leading vaccine manufacturers, and is steadily strengthening its position as a global biotechnology hub.

The programme included the ceremonial launch of Phase-III, interactions with researchers whose careers have been shaped through the initiative, and presentations showcasing the programme’s scientific achievements and long-term impact.

The minister said the programme demonstrates how long-term partnerships can accelerate scientific discovery, develop world-class human resources and build research ecosystems capable of addressing national as well as global health challenges.

He also called for greater participation by philanthropic institutions and industry, as India has abundant scientific talent and innovative ideas, but sustained financial partnerships remain essential for translating research into technologies, diagnostics and affordable healthcare solutions.

–IANS

aar/pk